Aktuell Apr 03, 2024 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...
News Apr 03, 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
S-GE Event Swiss Peer to Peer Conference 2024 Nov 21, 2024 09:00–17:00 Washington DC 20008 United States
Recordings Dec 15, 2021 Swiss Peer to Peer Conference 2021 This year’s Swiss Peer to Peer Conference was more relevant than ever with discussions concerning solutions for doing business in a post-Covid-19...